Evidence map›Paper›PMID 28634662›Full record

ArticleAIDS and behavior2017

HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking.

E Jennifer Edelman, Karsten Lunze, Debbie M Cheng, Dmitry A Lioznov, Emily Quinn, Natalia Gnatienko, Carly Bridden, Christine E Chaisson, Alexander Y Walley, Evgeny M Krupitsky and 2 more

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Provider-patient experiences and HIV care utilization among people living with HIV who inject drugs in St. Petersburg, Russia.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

E Jennifer EdelmanYale University School of Medicine, PO Box 208025, New Haven, CT, 06520-8088, USA. ejennifer.edelman@yale.edu.
Karsten LunzeBoston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Debbie M ChengBoston University School of Public Health, Boston, MA, USA.
Dmitry A LioznovFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russian Federation.
Emily QuinnBoston University School of Public Health, Boston, MA, USA.
Natalia GnatienkoBoston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Carly BriddenBoston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Christine E ChaissonBoston University School of Public Health, Boston, MA, USA.
Alexander Y WalleyBoston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Evgeny M KrupitskyFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russian Federation.
Anita RajUniversity of California - San Diego, San Diego, CA, USA.
Jeffrey H SametBoston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Boston University · USBoston Medical Center · USFirst Pavlov State Medical University of St. Petersburg · RUUniversity of California, San Diego · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Clinical Addiction Research and Education ProgramR25DA013582 · NIDA · BOSTON MEDICAL CENTER · PI JEFFREY H. SAMET, Alexander Yale Walley · 2001 to 2026
$8.9M
Yale Drug use, Addiction and HIV Research Scholars (DAHRS)K12DA033312 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Patrick O'Connor · 2013 to 2026
$7.2M
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected RussiansU01AA020780 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2011 to 2021
$4.4M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH CohortU01AA021989 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2012 to 2016
$3.3M
Maximizing Opportunity - HIV Prevention in Hospitalized Russian DrinkersR01AA016059 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2006 to 2010
$3.2M
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject DrugsR00DA041245 · NIDA · BOSTON MEDICAL CENTER · PI LUNZE, KARSTEN · 2018 to 2020
$906k
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject DrugsK99DA041245 · NIDA · BOSTON MEDICAL CENTER · PI LUNZE, KARSTEN · 2016 to 2017
$355k
National Institute of Allergy and Infectious Diseases P30AI042853National Institute on Alcohol Abuse and Alcoholism (US) P30AI042853National Institute on Alcohol Abuse and Alcoholism (US) U01AA020780National Institute on Drug Abuse (US) R25DA013582NCATS NIH HHS UL1 TR001863NIAAA NIH HHS R01 AA016059NIAAA NIH HHS R01AA016059NIAAA NIH HHS U01 AA020780NIAAA NIH HHS U01 AA021989NIAAA NIH HHS U01AA021989NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24AA020778NIAAA NIH HHS U24 AA020779NIAAA NIH HHS U24AA020779NIAID NIH HHS P30 AI042853NIDA NIH HHS K12 DA033312NIDA NIH HHS K12DA033312-03NIDA NIH HHS K99 DA041245NIDA NIH HHS K99DA041245NIDA NIH HHS R00 DA041245NIDA NIH HHS R25 DA013582
6 · The paper itself

Abstract

The link between HIV stigma with substance use is understudied. We characterized individuals with high HIV stigma and examined whether HIV stigma contributes to substance use among HIV-positive Russians reporting risky alcohol use. We analyzed data from HERMITAGE, a randomized controlled trial of 700 people living with HIV/AIDS (PLWHA) with past 6-month risky sex and risky alcohol use in St. Petersburg, Russia (2007-2011). Participants who were female and reported depressive symptoms and lower social support were more likely to endorse high HIV stigma (all p's < 0.001). In adjusted models, high HIV stigma was not significantly associated with the primary outcome unhealthy substance use and was not consistently associated with secondary substance use outcomes. Interventions to enhance social and mental health support for PLWHA, particularly women, may reduce stigma, though such reductions may not correspond to substantial decreases in substance use among this population.

Indexed as

Discrimination, PsychologicalPrejudiceSocial StigmaAdultAlcohol DrinkingDepressionFemaleHIV InfectionsHumansLongitudinal StudiesMaleMental HealthMiddle AgedRiskRussiaSocial SupportHIVRussiaStigmaSubstance use

Identifiers

PMID28634662
PMCPMC5856479
OpenAlexW2652764579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.